Brian Schnapp

A Prescription For Trouble: Pfizer Hit With FCPA Charges As Focus On Foreign Corruption In The Pharmaceutical Industry Continues

Supreme Court To Decide Important Class Certification Issue Regarding Class-Wide Damages Evidence

U.S. Supreme Court To Dive Deeply Into Antitrust: Granting Certiorari In Two Antitrust Cases